Showing results (351-360 of 686) with videos related to
Sort By:
Pageof 69
Alimentary Pharmacology & Therapeutics|November 4, 2004
A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitisR K Sterling, J J Salvatori, V A Luketic, et al.The Journal of Pharmacology and Experimental Therapeutics|May 18, 2010
Prevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathwaysRisheng Cao, Yiqiao Hu, Yun Wang, et al.The American Journal of Gastroenterology|December 22, 1999
Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantationR K Sterling, A J Sanyal, V A Luketic, et al.Transplantation|January 12, 1999
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantationR A Fisher, J M Ham, A Marcos, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2007
Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 yearsNevin Yilmaz, Mitchell L Shiffman, R Todd Stravitz, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|March 10, 2015
Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver diseaseHae-Ki Min, Faridoddin Mirshahi, Aurora Verdianelli, et al.The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.Hepatology (Baltimore, Md.)|September 20, 2017
C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in miceRunping Liu, Xiaojiaoyang Li, Zhiming Huang, et al.Journal of Hepatology|February 12, 2025
A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASHStephen A Harrison, Naim Alkhouri, Grisell Ortiz-Lasanta, et al.Biorxiv : the Preprint Server for Biology|March 27, 2026
PNPLA3 I148M is a novel regulator of bone mass independent of MASLDGalen M Goldscheitter, Mulugeta Seneshaw, Faridoddin Mirshahi, et al.Pageof 69